Successful Management of Treatment-Resistant Alopecia Areata with Platelet-Rich Plasma: A Case Series
Studysummary This study reported remarkable improvement in three patients with treatment-resistant alopecia areata after receiving autologous platelet-rich plasma injections, suggesting the potential for this approach and a need for further randomized, placebo-controlled trials.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
This case series documented the treatment of three patients with treatment-resistant alopecia areata (AA) using intra-dermal injections of autologous platelet rich plasma (PRP) every four weeks. All three patients exhibited significant improvement after multiple PRP sessions. The study concluded that autologous PRP is a safe and effective treatment for refractory AA and recommended further investigation through randomized, placebo-controlled trials.